EA200600252A1 - Новые сольваты n-гидрокси-4-(3-фенил-5-метилизоксазол-4-ил) бензолсульфонамида - Google Patents

Новые сольваты n-гидрокси-4-(3-фенил-5-метилизоксазол-4-ил) бензолсульфонамида

Info

Publication number
EA200600252A1
EA200600252A1 EA200600252A EA200600252A EA200600252A1 EA 200600252 A1 EA200600252 A1 EA 200600252A1 EA 200600252 A EA200600252 A EA 200600252A EA 200600252 A EA200600252 A EA 200600252A EA 200600252 A1 EA200600252 A1 EA 200600252A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hydroxy
phenyl
methilisoxazole
benzolsulphonamide
relates
Prior art date
Application number
EA200600252A
Other languages
English (en)
Other versions
EA008664B1 (ru
Inventor
Янош Фишер
Тамаш Фодор
Эгон Карпати
Иштванне Киш-Варга
Шандор Левай
Петер Эрдейи
Мария Зайерне Балаж
Анико Гере
Original Assignee
Рихтер Гедеон Ведьесети Дьяр Рт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рихтер Гедеон Ведьесети Дьяр Рт. filed Critical Рихтер Гедеон Ведьесети Дьяр Рт.
Publication of EA200600252A1 publication Critical patent/EA200600252A1/ru
Publication of EA008664B1 publication Critical patent/EA008664B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Изобретение относится к новым сольватам N-гидрокси-4-(3-фенил-5-метилизоксазол-4-ил)бензолсульфонамида формулы (I), где n равен 0 или 1 моль, сольват представляет воду, (С-С)-спирт, (С-С)-алкилэфир (С-С)-карбоновой кислоты или диоксан, и смеси сольватированных (где n=1) и несольватированных форм (где n=0). Кроме того, изобретение относится к способу их получения и их применению для лечения остеоартрита и ревматоидного артрита и болей при операции и первичной дисменореи, основанном на противовоспалительном и аналгезирующем фармакологическом действии, выявленном в экспериментах на моделях.
EA200600252A 2003-07-16 2004-07-16 Новые сольваты n-гидрокси-4-(3-фенил-5-метилизоксазол-4-ил)бензолсульфонамида EA008664B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0302219A HUP0302219A2 (hu) 2003-07-16 2003-07-16 N-hidroxi-4-(3-fenil-5-metil-izoxazol-4-il)-benzolszulfonamid-szolvátok, eljárás előállításukra és alkalmazásuk
PCT/HU2004/000077 WO2005007620A2 (en) 2003-07-16 2004-07-16 New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates

Publications (2)

Publication Number Publication Date
EA200600252A1 true EA200600252A1 (ru) 2006-06-30
EA008664B1 EA008664B1 (ru) 2007-06-29

Family

ID=89981516

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200600252A EA008664B1 (ru) 2003-07-16 2004-07-16 Новые сольваты n-гидрокси-4-(3-фенил-5-метилизоксазол-4-ил)бензолсульфонамида

Country Status (9)

Country Link
US (1) US20070093539A1 (ru)
EP (1) EP1643992A2 (ru)
JP (1) JP2007530424A (ru)
CN (1) CN1805744B (ru)
CA (1) CA2530175A1 (ru)
EA (1) EA008664B1 (ru)
HU (1) HUP0302219A2 (ru)
UA (1) UA83499C2 (ru)
WO (1) WO2005007620A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20040019A1 (it) * 2004-01-12 2004-04-12 Univ Bari Derivati isossazolici e loro impiego come inibitori della ciclossigenasi
US7989450B2 (en) 2008-01-11 2011-08-02 Universita' Degli Studi Di Bari Functionalized diarylisoxazoles inhibitors of ciclooxygenase
EP2145944B1 (en) 2008-07-14 2014-03-26 The Procter & Gamble Company A particle for imparting a fabric-softening benefit to fabrics treated therewith and that provides a desirable suds suppresion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2212836C (en) * 1995-02-13 2003-08-12 G.D. Searle & Co. Substituted isoxazoles for the treatment of inflammation
CN1308315C (zh) * 2001-10-02 2007-04-04 法玛西雅公司 制备苯磺酰基化合物的方法

Also Published As

Publication number Publication date
HU0302219D0 (en) 2003-09-29
HUP0302219A2 (hu) 2005-03-29
US20070093539A1 (en) 2007-04-26
UA83499C2 (en) 2008-07-25
EP1643992A2 (en) 2006-04-12
EA008664B1 (ru) 2007-06-29
JP2007530424A (ja) 2007-11-01
WO2005007620A2 (en) 2005-01-27
CN1805744A (zh) 2006-07-19
CA2530175A1 (en) 2005-01-27
WO2005007620A3 (en) 2005-03-10
CN1805744B (zh) 2010-11-03

Similar Documents

Publication Publication Date Title
PT1423391E (pt) Pirrolopirimidinas como agentes para a inibicao de proteases de cisteina
ATE361300T1 (de) Derivate von heteroarylnitrilverbindungen
EA200701302A1 (ru) 4-(n-фениламино)хиназолины/-хинолины в качестве ингибиторов тирозинкиназы
ATE377004T1 (de) Proteinkinaseinhibitoren
DE60331187D1 (de) Kinaseinhibitoren
LU91024I2 (fr) Valdecoxib ou ses sels pharmaceutiquement acceptables
MXPA04001930A (es) Inhibidores de proteasa de cisteina con estructura de 2-ciano-4amino-pirimidina y actividad inhibidora de catepsina k para el tratamiento de inflaciones y otras enfermedades.
EA200400073A1 (ru) Пирролопиримидины как ингибиторы протеинкиназы
IL171977A0 (en) Cyclic sulfonamides for inhibition of gamma-secretase
BR0112455A (pt) Métodos e dispositivos de sìntese contìnua de ferrato e métodos de tratamento, no local de uso, de uma mistura aquosa com, pelo menos, uma impureza, de purificação de água potável, de água de rejeito e de esgoto
EA200300717A1 (ru) Гетероциклилиндазольные и -азаиндазольные соединения в качестве 5-гидрокситриптамин-6-лигандов
DE60120104D1 (de) Neue Verwendung von Peptidverbindungen bei der Behandlung von nicht-neuropathischem Entzündungsschmerz
ATE511801T1 (de) Nähinstrument und -verfahren
ATE250063T1 (de) Pyrazolopyrimidinone, cgmp pde5 inhibitoren, zur behandlung von sexuellen funktionsstörungen
SV2003000633A (es) Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7
EA200600252A1 (ru) Новые сольваты n-гидрокси-4-(3-фенил-5-метилизоксазол-4-ил) бензолсульфонамида
EA200500261A1 (ru) Новые пролекарства (n-2-пиридил-n-2-гидроксикарбонилэтил)амида 1-метил-2-(4-амидинофениламинометил)бензимидазол-5-илкарбоновой кислоты, их получение и их применение в качестве лекарственных средств
EA200501557A1 (ru) Новый способ синтеза (2s)-индолин-2-карбоновой кислоты и использование в синтезе периндоприла
DK0954298T3 (da) 2,5-dihydroxybenzensulfonsyrederivater til behandling af seksuel dysfunktion
TR200100927A2 (tr) 4-[4-(Metilsulfonil)fenil]-3-fenilfuran-2(5H)-on'un Hazırlanması için proses
EA200400276A1 (ru) Способ лечения ревматоидного артрита коленного сустава
UA41755A (uk) Спосіб ендоскопічного лікування ендометріозу дугласової кишені

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU